GB00BRXB0C07
GB00BRXB0C07
Kiniksa Pharmaceuticals Interna
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 6.14B EUR | 4.99B EUR | 3.69B EUR |
Enterprise Value | 5.63B EUR | 4.82B EUR | 3.51B EUR |
Valuation Multiples | |||
Trailing P/E | 80.59x | 61.83x | 50.54x |
Forward P/E | 49.32x | -- | -- |
Price to Sales | 7.3x | 5.93x | 4.9x |
Price to Book | 9.51x | 7.62x | 6.1x |
EV/Revenue | 6.69x | 5.73x | 4.66x |
EV/EBITDA | 55.15x | 47.24x | 37.01x |
Price to FCF (P/FCF) | 48.66x | 27.27x | 22.48x |
EV/FCF | 44.61x | 26.36x | 21.38x |
FCF Yield | 2.06% | 3.67% | 4.45% |